KATIE ERNST: Open Payments
NPI 1851811327 · POULSBO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 28 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $246 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| UCB, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Incyte Corporation | 1 | $17 |
| Organon LLC | 1 | $12 |
Products named: TREMFYA, COSENTYX, Zoryve, Bimzelx, SKYRIZI, OPZELURA, VTAMA.
Industry payments across WA — which companies pay providers there.
